Published in AIDS Weekly, July 25th, 2005
Clevudine is a potent HBV antiviral currently in phase 3 clinical trials in Korea and has been the subject of earlier stage clinical trials under an investigational new drug (IND) application filed with the U.S. Food and Drug Administration (FDA). The financial terms of the agreement were not disclosed.
Clevudine is an oral,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.